Application of single cell genomics to focal epilepsies: A call to action

Brain Pathol. 2021 Jul;31(4):e12958. doi: 10.1111/bpa.12958.

Abstract

Focal epilepsies are the largest epilepsy subtype and associated with significant morbidity. Somatic variation is a newly recognized genetic mechanism underlying a subset of focal epilepsies, but little is known about the processes through which somatic mosaicism causes seizures, the cell types carrying the pathogenic variants, or their developmental origin. Meanwhile, the inception of single cell biology has completely revolutionized the study of neurological diseases and has the potential to answer some of these key questions. Focusing on single cell genomics, transcriptomics, and epigenomics in focal epilepsy research, circumvents the averaging artifact associated with studying bulk brain tissue and offers the kind of granularity that is needed for investigating the consequences of somatic mosaicism. Here we have provided a brief overview of some of the most developed single cell techniques and the major considerations around applying them to focal epilepsy research.

Keywords: focal epilepsy; single cell genomics; somatic variant.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Brain / pathology
  • Epilepsies, Partial / genetics*
  • Epilepsies, Partial / pathology*
  • Genetic Variation / genetics
  • Genomics
  • Humans
  • Malformations of Cortical Development / genetics*
  • Malformations of Cortical Development / pathology*
  • Mutation / genetics